Key Takeaway
See the average weight loss on Wegovy broken down month by month. Learn what to expect at each dose level and how your results compare to clinical trial data.
Wegovy patients lose an average of 5% of their body weight by month 3, 10% by month 6, and nearly 15% by month 12 to 15, following a predictable trajectory that aligns with the dose titration schedule. Knowing what each month should look like helps you stay motivated and on track.
As the first semaglutide formulation approved specifically for chronic weight management, Wegovy has the most strong clinical data of any GLP-1 weight loss medication. The STEP trial program tracked participants at regular intervals, giving us a detailed picture of month-by-month progress. what is Wegovy
Complete Month-by-Month Weight Loss Timeline
Wegovy follows a 16-week dose escalation from 0.25 mg to the 2.4 mg maintenance dose. Each dose increase brings more weight loss, and progress continues well after reaching the full dose.
| Month | Weekly Dose | Cumulative % Lost | Cumulative Pounds Lost | Avg Monthly Loss |
|---|---|---|---|---|
| 1 | 0.25 mg | 1.5% | 3 to 4 lbs | 3 to 4 lbs |
| 2 | 0.5 mg | 3.5% | 7 to 8 lbs | 4 to 5 lbs |
| 3 | 1.0 mg | 5.5% | 12 to 13 lbs | 4 to 5 lbs |
| 4 | 1.7 mg | 7.5% | 17 to 18 lbs | 4 to 5 lbs |
| 5 | 2.4 mg | 9.0% | 20 to 21 lbs | 3 to 4 lbs |
| 6 | 2.4 mg | 10.5% | 24 to 25 lbs | 3 to 4 lbs |
| 8 | 2.4 mg | 12.5% | 28 to 29 lbs | 2 to 3 lbs |
| 10 | 2.4 mg | 13.5% | 31 to 32 lbs | 1 to 2 lbs |
| 12 | 2.4 mg | 14.5% | 33 to 34 lbs | 1 to 2 lbs |
| 15 (end of STEP 1) | 2.4 mg | 14.9% | 34 to 35 lbs | 0.5 to 1 lb |
How Each Phase
The Titration Phase (Months 1 to 4)
During the first four months, your dose increases every four weeks. This phase accomplishes two things simultaneously: it allows your gastrointestinal system to adjust to the medication, and it provides progressively stronger appetite suppression. For a complete cost breakdown, see our cheapest semaglutide options.
View data table
| Category | Mean Body Weight Loss (%) | Detail |
|---|---|---|
| Tirzepatide | 22 | ~22% body weight at 72 wks |
| Semaglutide | 15 | ~15% body weight at 68 wks |
| Liraglutide | 8 | ~8% body weight at 56 wks |
| Retatrutide | 24 | ~24% in Phase 2 trial |
The titration phase accounts for about half of the total weight loss you'll experience over the first year. Monthly loss rates are typically at their highest during months 2 through 4, averaging 4 to 5 pounds per month. This is when most patients report the most dramatic shift in their eating habits and hunger levels. Wegovy titration phase guide
Common experiences during titration include:
- Noticeable reduction in hunger by week 2 to 3
- Early fullness during meals, requiring smaller portions
- Decreased interest in snacking between meals
- Mild to moderate nausea, especially in the days following a dose increase
- Changes in taste preferences, with some patients finding sweet or fatty foods less appealing
The Acceleration Phase (Months 5 to 8)
Once you reach the 2.4 mg maintenance dose, the medication's full effect kicks in. Weight loss continues at a strong pace of 2 to 4 pounds per month. This is when the cumulative loss becomes very noticeable to yourself and others.
By month 6, most patients have crossed the 10% body weight loss threshold. This milestone is clinically significant because research shows that losing 10% of body weight produces meaningful improvements in blood pressure, cholesterol, blood sugar, joint stress, and overall cardiovascular risk. health milestones during weight loss
By month 8, cumulative losses approach 12% to 13%, and many patients have completed their wardrobe transition. Energy levels are typically much higher, and physical activity becomes easier and more enjoyable.
The Consolidation Phase (Months 9 to 15)
During the later months, the rate of weight loss slows to 1 to 2 pounds per month. This deceleration is a normal biological response. As your body mass decreases, fewer calories are needed to maintain your weight, and the caloric deficit created by reduced appetite becomes smaller relative to your new lower weight.
But this phase is still important. Weight continues to come off, and the STEP 5 trial[2] showed that patients continue to lose or at minimum maintain weight through at least 104 weeks (2 years) of treatment. Patience during this phase pays dividends.
What the STEP Trials Tell Us About Monthly Variation
Not every patient follows the average curve. The STEP trials reveal significant variation in monthly weight loss rates.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →Super Responders
Approximately 32% of STEP 1 participants lost 20% or more of their body weight. These super responders often lose weight faster than average in every month and may reach 20% loss by month 8 to 10 rather than needing 15 months.
Moderate Responders
The majority of patients (roughly 50%) fall in the moderate responder category, losing between 10% and 20% of body weight. Their monthly trajectory closely matches the averages shown in the table above.
Lower Responders
About 18% of patients lost between 5% and 10% of body weight, and approximately 14% lost less than 5%. Lower response may be due to metabolic differences, medication interactions, inconsistent adherence, or other factors. If you fall into this category, discussing your situation with your provider is important, as adjustments may improve your outcomes. not losing weight on semaglutide
How to Evaluate Your Monthly Progress
We recommend these guidelines for assessing whether your Wegovy treatment is on track.
Month 1 checkpoint: Any weight loss is a positive sign. Even 1 to 2 pounds indicates the medication is having an effect. Focus on noting changes in appetite and hunger patterns rather than fixating on the scale.
Month 3 checkpoint: By this point, you should ideally have lost at least 3% to 5% of your starting weight. If you haven't, discuss potential barriers with your provider.
Month 6 checkpoint: Losing at least 5% of starting weight by month 6 is considered a positive response. Most patients on Wegovy exceed this threshold by a comfortable margin. If you're below 5%, your provider may investigate contributing factors or consider alternative treatments.
Month 12 checkpoint: At this stage, assess your total health improvement holistically. Beyond weight, evaluate changes in blood pressure, blood sugar, cholesterol, waist circumference, energy, sleep quality, and joint comfort.
Strategies for Strong Monthly Results
Weigh Yourself Consistently
Weigh yourself at the same time each day (ideally first thing in the morning after using the bathroom) and track the weekly average. Daily fluctuations are normal and don't reflect actual fat changes. The weekly and monthly trend is what matters. how to track weight loss accurately
Prioritize High-Protein Meals
With reduced appetite on Wegovy, you eat fewer total calories. Making sure a high percentage of those calories come from protein (at least 25 to 30 grams per meal) helps preserve muscle mass, which supports metabolism and leads to better body composition outcomes. protein on GLP-1 medication
Move Your Body Regularly
Patients who exercise regularly tend to lose an extra 1 to 2 pounds per month compared to sedentary patients. Walking is the most accessible form of exercise and pairs well with Wegovy treatment. Aim for 7,000 to 10,000 steps per day as a starting goal.
Manage Side Effects Proactively
Nausea, constipation, and diarrhea can interfere with nutrition and hydration, which can indirectly affect weight loss progress. Working with your provider to manage side effects ensures you stay on track and avoid treatment interruptions. Wegovy side effect management
Frequently Asked Questions
Is it normal to lose only 2 pounds in the first month on Wegovy?
Yes. The 0.25 mg starting dose is sub-therapeutic for weight loss. Losing 2 to 4 pounds in month 1 is typical and expected. Significantly more weight loss begins once you reach the 0.5 mg and 1.0 mg doses. Don't be discouraged by modest early results.
Which month produces the most weight loss on Wegovy?
Months 2 through 5 typically produce the fastest rate of weight loss, coinciding with the dose increases from 0.5 mg to 2.4 mg. Total monthly losses during this period average 3 to 5 pounds for most patients.
Should I be worried if my weight loss plateaus for a month?
A one-month plateau isn't uncommon and usually resolves on its own. Water retention, hormonal fluctuations, changes in exercise (which can increase muscle mass), and dietary variations can all cause temporary stalls. If a plateau lasts more than 6 to 8 weeks, discuss it with your provider.
Does Wegovy weight loss continue after 12 months?
Yes, though at a slower rate. The STEP 5 trial showed that patients continued to lose or maintain weight through 24 months of treatment. Some patients experience additional modest weight loss between months 12 and 24, while others stabilize at their month 12 weight. Both outcomes are positive.
Medical References
- Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. [PubMed | ClinicalTrials.gov | DOI]
- Garvey WT, Batterham RL, Bhatt DL, et al. Two-year effects of semaglutide in adults with overweight or obesity (STEP 5). Nat Med. 2022;28(10):2083-2091. [PubMed | ClinicalTrials.gov | DOI]
Monitor Your Monthly Progress with FormBlends
FormBlends provides physician-supervised Wegovy and semaglutide treatment with structured monthly check-ins. Our providers track your weight loss month by month, make dose adjustments when appropriate, and help you troubleshoot any obstacles to progress. get started with FormBlends
Start your consultation today and begin your Wegovy weight loss process with expert support at every stage.
Talk to a licensed provider
Start your free assessment. A licensed provider reviews every request before anything is prescribed, and not everyone qualifies.
Start the assessment →